Open Translation and Analysis Center Authorization Act

Summary

Open Translation and Analysis Center Authorization Act This bill establishes the Open Translation and Analysis Center as a federally funded research and development center sponsored by the Department of State. The center must disseminate translations and analysis of foreign language materials from China and other countries of strategic interest, with a particular focus on government materials (e.g., documents, reports, and speeches of political and military leadership). To carry out its activities, the center must (1) select appropriate materials for translation and analysis; (2) train analysts and linguists; (3) use technologies to expedite translations; and (4) otherwise coordinate its work with federal agencies, foreign allies, and others. Specifically, the center must cooperate and consult with relevant federal agencies and stakeholders, including grantees of the United States Agency for Global Media and research organizations. The center may consult with foreign governments if the State Department certifies that the consultation serves U.S. national interests. Additionally, the center must maintain a publicly available website of all translations and analyses that are not subject to copyright or intellectual property protections. Materials subject to those protections must be made available at no cost on a private website to federal employees and contractors and members of Congress and their staff. The bill designates the State Department as the primary sponsor of the center. However, the State Department may enter into sponsorship agreements with other federal agencies, such as the Central Intelligence Agency.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 28 July 2021

   Introduced

   Referred to the House Committee on Foreign Affairs.

   Source: IntroReferral

2. 28 July 2021

   Introduced

   Introduced in House

   Source: IntroReferral

3. 28 July 2021

   Introduced

   Introduced in House

   Source: IntroReferral

4. 4 August 2021

   Referred

   Referred to the Subcommittee on Asia, the Pacific, Central Asia and Nonproliferation.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 28 July 2021 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 28 July 2021

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 28 July 2021

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 28 July 2021

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Castro, Joaquin [D-TX-20] · D · Sponsor
• Rep. Gallagher, Mike [R-WI-8] · R · Sponsor
• Rep. Keating, William R. [D-MA-9] · D · Sponsor
• Rep. Fitzpatrick, Brian K. [R-PA-1] · R · Sponsor
• Rep. Kim, Young [R-CA-40] · R · Sponsor
• Rep. Lieu, Ted [D-CA-36] · D · Cosponsor
• Rep. Titus, Dina [D-NV-1] · D · Cosponsor
• · hsfa00 · Standing

Related records

• related to ← Pharmaceutical Research Transparency Act of 2022